Metronidazole and Epstein-barr virus associated lymphoproliferative disorder - a phase IV clinical study of FDA data

Summary:

Epstein-barr virus associated lymphoproliferative disorder is found among people who take Metronidazole, especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Metronidazole and have Epstein-barr virus associated lymphoproliferative disorder. It is created by eHealthMe based on reports of 49,154 people who have side effects when taking Metronidazole from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 03, 2022

49,154 people reported to have side effects when taking Metronidazole.
Among them, 6 people (0.01%) have Epstein-barr virus associated lymphoproliferative disorder.


What is Metronidazole?

Metronidazole has active ingredients of metronidazole. It is often used in vaginitis bacterial. eHealthMe is studying from 50,510 Metronidazole users for its effectiveness, alternative drugs and more.

What is Epstein-barr virus associated lymphoproliferative disorder?

Epstein-barr virus associated lymphoproliferative disorder (lymphocytes are produced in excessive quantities associated with epstein-barr virus) is found to be associated with 341 drugs and 258 conditions by eHealthMe.

Number of Metronidazole and Epstein-barr virus associated lymphoproliferative disorder reports submitted per year:

Could Metronidazole cause Epstein-barr virus associated lymphoproliferative disorder?

Time on Metronidazole when people have Epstein-barr virus associated lymphoproliferative disorder *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Epstein-barr virus associated lymphoproliferative disorder when taking Metronidazole *:

  • female: 33.33 %
  • male: 66.67 %

Age of people who have Epstein-barr virus associated lymphoproliferative disorder when taking Metronidazole *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 33.33 %
  • 30-39: 0.0 %
  • 40-49: 33.33 %
  • 50-59: 33.33 %
  • 60+: 0.0 %

Common drugs people take besides Metronidazole *:

  1. Slow-K: 4 people, 66.67%
  2. Cyclosporine: 4 people, 66.67%
  3. Nystatin: 4 people, 66.67%
  4. Omeprazole: 3 people, 50.00%
  5. Vancomycin: 2 people, 33.33%
  6. Furosemide: 2 people, 33.33%
  7. Fluconazole: 2 people, 33.33%
  8. Chlorpheniramine Maleate: 2 people, 33.33%
  9. Chloramphenicol: 2 people, 33.33%
  10. Calcitriol: 2 people, 33.33%

Common side effects people have besides Epstein-barr virus associated lymphoproliferative disorder *:

  1. White Blood Cell Count Increased: 2 people, 33.33%
  2. Headache (pain in head): 2 people, 33.33%
  3. Haematocrit Decreased: 2 people, 33.33%
  4. Gastrointestinal Necrosis (destruction of gastrointestinal organ): 2 people, 33.33%
  5. Gastrointestinal Hypermotility (over activity of the intestinal tract): 2 people, 33.33%
  6. Gamma-Glutamyltransferase Increased: 2 people, 33.33%
  7. Fever: 2 people, 33.33%
  8. Febrile Neutropenia (fever with reduced white blood cells): 2 people, 33.33%
  9. Eosinophil Count Decreased: 2 people, 33.33%
  10. Colon Cancer: 2 people, 33.33%

Common conditions people have *:

  1. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 2 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Metronidazole and have Epstein-barr virus associated lymphoproliferative disorder?

Check whether Epstein-barr virus associated lymphoproliferative disorder is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Epstein-barr virus associated lymphoproliferative disorder and when was it recovered:

Expand to all the drugs that have ingredients of metronidazole:

Alternative drugs to, pros and cons of Metronidazole:

Common Metronidazole side effects:

Browse all side effects of Metronidazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Epstein-barr virus associated lymphoproliferative disorder treatments and more:

COVID vaccines that are related to Epstein-barr virus associated lymphoproliferative disorder:

Common drugs associated with Epstein-barr virus associated lymphoproliferative disorder:

All the drugs that are associated with Epstein-barr virus associated lymphoproliferative disorder:

Common conditions associated with Epstein-barr virus associated lymphoproliferative disorder:

All the conditions that are associated with Epstein-barr virus associated lymphoproliferative disorder:

How the study uses the data?

The study uses data from the FDA. It is based on metronidazole (the active ingredients of Metronidazole) and Metronidazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: